We are live on ! Find out more
MM

MWG Management Portfolio holdings

AUM $81.3M
1-Year Est. Return 2.28%
This Fund
S&P 500
This Quarter Est. Return
+15.3%
1 Year Est. Return
+2.28%
3 Year Est. Return
-59.16%
5 Year Est. Return
-10.97%
10 Year Est. Return
AUM
$135M
AUM Growth
+$16.2M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BEAM icon
1
Beam Therapeutics
BEAM
$2.71B
$77.5M 57.42%
2,346,934
LYEL icon
2
Lyell Immunopharma
LYEL
$317M
$45M 33.29%
1,008,117
PRME icon
3
Prime Medicine
PRME
$551M
$12.5M 9.29%
1,792,210

Similar funds

MWG Management's Q1 2024 Portfolio in Review

As of Q1 2024, MWG Management held 3 positions worth $135M, up 14% from $119M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 0%. MWG Management opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • MWG Management's ten largest holdings make up 100% of its $135M portfolio in Q1 2024.
  • MWG Management opened 0 new positions and closed 0 in Q1 2024.
  • MWG Management's portfolio value rose 14% quarter-over-quarter to $135M.

Based on MWG Management's 13F filing for Q1 2024, filed 14 May 2024.